About Us

The Institute for Translational Sciences (ITS) aims to train a new generation of clinical and translational researchers, engage stakeholders and communities in research, address barriers to clinical and translational research, and advance translational research through team-based approaches. The ITS, established in 2007, is the academic home of UTMB’s Clinical Translational Sciences Award (CTSA), funded by the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS). CTSA institutions work together to speed the translation of research discoveries into improved health. 

Read More


Our Mission

The ITS is the academic home for translational research at UTMB. Translational research is the application and refinement of a discovery or practice intervention into clinical practice to improve the health of our community.
We develop, evaluate and disseminate best practices for novel training and leadership programs in
translational science.



  • Call for Applications KL2 Provost Scholar Award

    September 11, 2020, 08:57 AM by Gilbert Mireles
    The Institute for Translational Sciences’ Translational Research Scholars Career Development (ITS Scholars) program is accepting applications for funding. The competing award for this current call for applications is the ITS Scholars’ Provost’s Scholar Award, which is similar to the KL2 Scholar award, in the monetary and mentorship support that it provides, but also has a significant component of institutional funding which forms the support mechanism.
  • Pre-Application Workshops for the UTMB Health Technology Commercialization Program (TCP)

    September 4, 2020, 08:09 AM by Gilbert Mireles
    Through a partnership between the Chief Research Office and The Office of Technology Transfer, The Technology Commercialization Program (TCP) provides seed funds to support commercialization of UTMB discoveries. All UTMB employees, students, staff, and trainees are eligible to submit an application.
  • National COVID Cohort Collaborative (N3C) at UTMB

    September 2, 2020, 10:16 AM by Gilbert Mireles
    The National Center for Advancing Translational Sciences of the National Institutes of Health has launched a centralized, secure enclave to store and study vast amounts of patient medical record data from those individuals that have had a test for coronavirus disease across the country. It is part of an effort called the National COVID Cohort Collaborative (N3C).
  • Rapid Response Funding Available for Clinical & Translational Pilot Awards

    June 30, 2020, 18:51 PM by Lisa Velasquez
    Funds are available to support innovative, investigator-initiated studies that have potential to develop into clinical trials related to either Precision Medicine or COVID-19.


  • TRCC (Texas Regional CTSA Consortium) Quantitative Seminar Series

    Date/Time: , 2020 - -
    This seminar contributes to achieving one or more of the CTSA core competencies in the category of Statistical Approaches, “Evaluating Community-Based Translational Interventions Using Historical Controls: Propensity Score vs. Disease Risk Score Approach”.